Abstract
Caspase-9 is believed to play an essential role in sepsis-induced lymphocyte apoptosis. The aim of this study was therefore to evaluate its contribution within the caspase-dependent apoptosis pathway in a murine model of polymicrobial sepsis. Local injections of Z-LEHD-fmk, a specific caspase-9 inhibitor, into thymi of septic mice led to the complete inhibition of caspase-9, decreased apoptosis of resident tissue cells, and, in addition, reduced further downstream caspase-3 activity. In contrast to its systemic administration, only local injections improved the overall survival of septic mice. However, local injections of a pancaspase inhibitor (Z-VAD-fmk) did not improve survival, although caspase-3 activity was reduced to a similar degree as by the administration of Z-LEHD-fmk. These results indicate that local apoptosis of lymphatic tissue in polymicrobial sepsis is processed dependent of caspase-9 and suggests alternative caspase-dependent beneficial effects, which may determine a positive outcome.
Similar content being viewed by others
Abbreviations
- Apaf-1:
-
Apoptosis protease activating factor 1
References
Stone R (1994) Search for sepsis drugs goes on despite past failures. Science 264:365–367
Wang SD, Huang KJ, Lin YS, Lei HY (1994) Sepsis-induced apoptosis of the thymocytes in mice. J Immunol 152:5014–5021
Hiramatsu M, Hotchkiss RS, Karl IE, Buchman TG (1997) Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock 7:247–253
Hotchkiss RS, Swanson PE, Freeman BD et al (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27:1230–1251
Cheadle WG, Pemberton RM, Robinson D, Livingston DH, Rodriguez JL, Polk HC Jr (1993) Lymphocyte subset responses to trauma and sepsis. J Trauma 35:844–849
Bone RC (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24:1125–1128
Zheng TS, Flavell RA (2000) Divinations and surprises: genetic analysis of caspase function in mice. Exp Cell Res 256:67–73
Skoberne M, Beignon AS, Bhardwaj N (2004) Danger signals: a time and space continuum. Trends Mol Med 10:251–257
Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL (2001) Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J 15:879–892
Tinsley KW, Cheng SL, Buchman TG et al (2000) Caspases-2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis. Shock 13:1–7
Fukuzuka K, Rosenberg JJ, Gaines GC et al (1999) Caspase-3-dependent organ apoptosis early after burn injury. Ann Surg 229:851–858; discussion 858–859
Hotchkiss RS, Tinsley KW, Swanson PE et al (1999) Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A 96:14541–14546
Mignon A, Rouquet N, Fabre M et al (1999) LPS challenge in d-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med 159:1308–1315
Hakem R, Hakem A, Duncan GS et al (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94:339–352
Zacks DN, Zheng QD, Han Y, Bakhru R, Miller JW (2004) FAS-mediated apoptosis and its relation to intrinsic pathway activation in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci 45:4563–4569
Colak A, Karaoglan A, Barut S, Kokturk S, Akyildiz AI, Tasyurekli M (2005) Neuroprotection and functional recovery after application of the caspase-9 inhibitor Z-LEHD-fmk in a rat model of traumatic spinal cord injury. J Neurosurg Spine 2:327–334
Gamen S, Anel A, Perez-Galan P et al (2000) Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells. Exp Cell Res 258:223–235
Ozoren N, Kim K, Burns TF, Dicker DT, Moscioni AD, El-Deiry WS (2000) The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 60:6259–6265
Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331–335
Oberholzer A, Souza SM, Tschoeke SK et al (2005) Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23:488–493
Ohmoto K, Yamamoto S (2005) Serum interleukin-6 and interleukin-10 in patients with acute pancreatitis: clinical implications. Hepatogastroenterology 52:990–994
Manley MO, O'Riordan MA, Levine AD, Latifi SQ (2005) Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Shock 23:521–526
Hotchkiss RS, Swanson PE, Knudson CM et al (1999) Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 162:4148–4156
Brunetti M, Martelli N, Colasante A, Piantelli M, Musiani P, Aiello FB (1995) Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood 86:4199–4205
Ayala A, Herdon CD, Lehman DL, DeMaso CM, Ayala CA, Chaudry IH (1995) The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by corticosteroids but not tumor necrosis factor. Shock 3:259–267
Tripathi P, Hildeman D (2004) Sensitization of T cells to apoptosis—a role for ROS? Apoptosis 9:515–523
Hauser B, Bracht H, Matejovic M, Radermacher P, Venkatesh B (2005) Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies. Anesth Analg 101:488–498
Oates JC, Gilkeson GS (2004) Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. J Investig Med 52:62–71
Karawajew L, Rhein P, Czerwony G, Ludwig WD (2005) Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood 105:4767–4775
Erster S, Moll UM (2005) Stress-induced p53 runs a transcription-independent death program. Biochem Biophys Res Commun 331:843–850
Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22:9030–9040
Jaattela M (2004) Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 23:2746–2756
Li P, Nijhawan D, Budihardjo I et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489
Slee EA, Harte MT, Kluck RM et al (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144:281–292
Daemen MA, van 't Veer C, Denecker G et al (1999) Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541–549
Hotchkiss RS, Chang KC, Swanson PE et al (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 1:496–501
Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P (2003) Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat Immunol 4:387–393
Luschen S, Ussat S, Scherer G, Kabelitz D, Adam-Klages S (2000) Sensitization to death receptor cytotoxicity by inhibition of Fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. J Biol Chem 275:24670–24678
Perfettini JL, Kroemer G (2003) Caspase activation is not death. Nat Immunol 4:308–310
Acknowledgement
Supported in part by grants R37 GM-40586 and P30 HL-59412 awarded by the National Institutes of Health, USPHS.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oberholzer, C., Tschoeke, S.K., Moldawer, L.L. et al. Local thymic caspase-9 inhibition improves survival during polymicrobial sepsis in mice. J Mol Med 84, 389–395 (2006). https://doi.org/10.1007/s00109-005-0017-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-005-0017-1